Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Issue 2 (May 2015)

• Record Type: Journal Article
• Authors: Wu, Kuan-Li; Tsai, Ming-Ju; Yang, Chih-Jen; Chang, Wei-An; Hung, Jen-Yu; Yen, Chun-Ju; Shen, Chi-Hsiang; Kuo, Tzu-Yu; Lee, Jui-Ying; Chou, Shah-Hwa; Liu, Ta-Chih; Chong, Inn-Wen; Huang, Ming-Shyan
• Is Part Of: Lung cancer. Volume 88:Issue 2(2015:May)
• Page Start: 187
• Page End: 194
• Publication Date: 2015-05
• Subjects: Lungs -- Cancer -- Periodicals; Lung Neoplasms -- Abstracts; Lung Neoplasms -- Periodicals; Poumons -- Cancer -- Périodiques; Lungs -- Cancer; Periodicals; Electronic journals; Electronic journals; 616.99424
• DOI: 10.1016/j.lungcan.2015.02.012
• Languages: English
• ISSNs: 0169-5002

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Gefitinib has been a first-line therapy for advanced NSCLC with EGFR mutation.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Treatment response to gefitinib varies in patients with susceptible EGFR mutations.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Liver metastasis predicts poorer PFS and OS in stage IV lung adenocarcinoma.</p> </list-item> </list> </p> </sec> </abstract>